Skip to main content

Table 1 Patient and HV characteristics

From: IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia

  HV AML
No. patients 30 30
Gender   
 Male 15 (50%) 14 (47%)
 Female 15 (50%) 16 (53%)
Median age, years (range) 63 (38–87) 68 (35–85)
Subtype according to FAB classification
 M0–M1   6 (20%)
 M2   9 (30%)
 M4   4 (13.3%)
 M5   9 (30%)
 M6   1 (3.3%)
 M7   1 (3.3%)
Karyotype
 Normal   14 (47%)
 Undefined   4 (13%)
 Complex   3 (10%)
Trisomy chr 8   3 (10%)
 t(8–21)   2 (7%)
 Tetrasomy chr 21   1 (3%)
 Inv chr 3   1 (3%)
 Del chr 7   1 (3%)
 Del chr 20   1 (3%)
Molecular mutations
 FLT3/NPM wt   17 (57%)
 FLT3 ITD   4 (13%)
 FLT3 mut NPM mut   3 (10%)
 FLT3 mut NPM wt   1 (3%)
 FLT3 wt NPM mut   1 (3%)
 AML-ETO   2 (7%)
 Undefined   2 (7%)
  1. FAB French-American-British, chr chromosome, t translocation, Inv inversion, Del deletion, wt wild type, mut mutated.